Many at-risk Americans either do not know about PrEP or don't have access. Here's why raising awareness is key to ending the ...

HIV drugs can prevent HTLV-1 transmission and disease in mice, paving the way for trials to fight this long-overlooked, ...

ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers successfully suppressed the virus in mice and discovered a way to kill infected cells ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

A breakthrough HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and ...

DUBLIN--(BUSINESS WIRE)--The "HIV Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for HIV Drugs was valued at US$32.8 Billion ...

A secondary analysis of a large trial shows that exposure to the HIV drug abacavir is linked to an elevated risk for major cardiovascular events in people with HIV.

In 2016, the health ministry prohibited the sale of 344 fixed-dose combination drugs.However, after the move was challenged in the Delhi High Court by drug manufacturers, only 14 drugs were banned ...

Hepatitis C drugs that contain sofosbuvir, such as Sovaldi and Harvoni, are often used in combination with other medications to combat co-infections with different viruses, such as HIV and ...

GENEVA, (CMC)-The World Health Organization (WHO) on Monday advised countries, including those in the Caribbean to ensure ...

Acquired immune deficiency syndrome, or AIDS, caused by the human immunodeficiency virus (HIV), weakens the body's immune ...